September 17, 2020
Takeda Pharmaceutical said on September 16 that it is selling TachoSil Fibrin Sealant Patch to Corza Health for €350 million. Takeda previously agreed to divest the product to Ethicon, a unit of Johnson & Johnson, but the deal was blocked...read more